# Intracardiac CrYoablation for AtrioVentricular Nodal Reentrant Tachycardia

Study · id `cardio:ct-nct01426425` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT01426425](<https://clinicaltrials.gov/study/NCT01426425>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT01426425

Browse, organ or system: Heart  
Browse, condition area: Heart rhythm problems  

## In plain language

A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 572 participants.

## Technical summary

Registry record NCT01426425. Allocation not applicable; no masking; primary purpose treatment. Start 2012-05 (registry gives no type); primary completion 2015-09 (actual). Results posted on 2017-03-31.

## Key facts

- Design: Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase: Phase 3
- Enrolled: 572 participants (enrolled count; ClinicalTrials.gov record NCT01426425, source copy `cardio:ctgov-nct01426425-2025-02-13`, retrieved 2026-10-26)
- Start date: 2012-05 (registry gives no type) (ClinicalTrials.gov record NCT01426425, source copy `cardio:ctgov-nct01426425-2025-02-13`, retrieved 2026-10-26)
- Primary completion: 2015-09 (actual) (ClinicalTrials.gov record NCT01426425, source copy `cardio:ctgov-nct01426425-2025-02-13`, retrieved 2026-10-26)
- Completion: 2016-09 (actual) (ClinicalTrials.gov record NCT01426425, source copy `cardio:ctgov-nct01426425-2025-02-13`, retrieved 2026-10-26)
- Results first posted: 2017-03-31 (ClinicalTrials.gov record NCT01426425, source copy `cardio:ctgov-nct01426425-2025-02-13`, retrieved 2026-10-26)
- Countries: United States; Canada (ClinicalTrials.gov record NCT01426425, source copy `cardio:ctgov-nct01426425-2025-02-13`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct01426425-2025-02-13`, retrieved 2026-10-26)

## The registry's words

- Brief title: Intracardiac CrYoablation for AtrioVentricular Nodal Reentrant Tachycardia
- Condition: AtrioVentricular Nodal Reentrant Tachycardia
- Condition: Supraventricular Tachycardia
- Condition: Heart Disease
- Intervention (Device): Freezor Xtra Cryoablation Catheter
- Lead sponsor: Medtronic Cardiac Ablation Solutions
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Arrhythmia (heart rhythm problems) (`cardio:arrhythmia`)
- Registry condition terms include this condition: Supraventricular tachycardia (`cardio:supraventricular-tachycardia`)
- Registry lists this organization as the lead sponsor: Medtronic Cardiac Ablation Solutions (`cardio:org-medtronic-cardiac-ablation-solutions`)

## Provenance

Content hash: 45088ca3df174793f445b4b2e91285deaf1b49a610edcde7f42a28ded4e1dd11
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
